ABSTRACT GABA A receptors mediate fast inhibitory neurotransmission in the central nervous system (CNS), and approximately half of these receptors contain ␣1 subunits. GABA A receptor ␣1 subunits are important for receptor assembly and specific pharmacological responses to benzodiazepines. Plasticity in GABA A receptor ␣1 subunit expression is associated with changes in CNS excitability observed during normal brain development, in animal models of epilepsy, and upon withdrawal from alcohol and benzodiazepines. To examine the role of ␣1 subunitcontaining GABA A receptors in vivo, we characterized receptor subunit expression and pharmacological properties in cerebral cortex of knockout mice with a targeted deletion of the ␣1 subunit. The mice are viable but exhibit an intention tremor. Western blot analysis confirms the complete loss of ␣1 subunit peptide expression. Stable adaptations in the expression of several GABA A receptor subunits are observed in the fifth to seventh generations, including decreased expression of ␤2/3 and ␥2 subunits and increased expression of ␣2 and ␣3 subunits. There was no change in ␣4, ␣5, or ␦ subunit peptide levels in cerebral cortex. Knockout mice exhibit loss of over half of GABA A receptors measured by [ 3
Cl
Ϫ uptake in cerebral cortical synaptoneurosomes are reduced in ␣1 Ϫ/Ϫ mice. Furthermore, knockout mice exhibit increased bicuculline-induced seizure susceptibility compared with wild-type mice. These data emphasize the significance of ␣1 subunit expression and its involvement in the regulation of CNS excitability.
GABA A receptors are a family of ligand-gated ion channels that are the major target of the endogenous inhibitory neurotransmitter (GABA) and maintain the majority of fast inhibitory ion currents in the CNS. They are pentamers composed of subunits (␣1-6, ␤1-3, ␥1-3, ␦, ⑀, , and ) that are encoded by a gene family with diverse expression patterns (Sieghart et al., 1999) . GABA A receptors are the targets of several classes of drugs, including benzodiazepines (BZDs), barbiturates, alcohols, neurosteroids, and inhalation anesthetics (Sieghart, 1995) . Additionally, GABA A receptors have been shown to be involved in epilepsy (DeLorey et al., 1998) , various behavioral states such as depression and anxiety (Benson et al., 1998; Crestani et al., 1999) , and learning and memory (Flood et al., 1992; DeLorey et al., 1998) .
Prevailing theory suggests that the subunit composition of an individual GABA A receptor confers a unique pharmacology that dictates the binding characteristics, functional capacity, and role of the receptor in maintaining the inhibitory tone of the CNS. The GABA A receptor ␣1 subunit is the most abundant ␣ subunit in adult brain, highly expressed throughout most brain regions, and is a component of ϳ50% of GABA A receptors (Duggan and Stephenson, 1990; McKernan et al., 1991) . Recombinant expression studies have indicated that ␣1 subunit expression confers specific pharmacological properties to the receptor, including GABA sensitivity (Levitan et al., 1988) and maximal efficacy of benzodiazepines (Puia et al., 1991) . Furthermore, the expression of ␣1 versus ␣2, ␣3, and ␣5 in ␣␤␥2 receptors results in differential affinity for several benzodiazepine site ligands (Pritchett et al., 1989; Pritchett and Seeburg, 1990) .
Recently, several studies have begun to describe the in vivo role of the ␣1 subunit in GABA A receptor pharmacology, function, and related behavior. An association between heightened CNS excitability and reduced ␣1 subunit expression has been observed during ontogenic development, alcohol dependence and withdrawal, and in animal models of temporal lobe epilepsy (Aicardi and Chevrie, 1970; Mecarelli et al., 1988; Morrow et al., 1990; Devaud et al., 1997; BrooksKayal et al., 1998; Poulter et al., 1999) . Previous studies have suggested various roles for ␣ subunit isoforms in specific BZD-related behaviors (Mohler et al., 1996; Rudolph et al., 1999; Crestani et al., 2000; Low et al., 2000) . Recently, the production of two independent ␣1 knockout mouse lines has been described (Sur et al., 2001; Vicini et al., 2001) . Global deletion of the ␣1 subunit gene results in viable mice that are surprisingly normal. Although initial electrophysiological studies revealed diminished mIPSCs and loss of zolpideminduced prolongation of mIPSC decay rates in cerebellar stellate cells (Vicini et al., 2001) , we have now analyzed GABA A receptor subunit expression, ligand binding, and muscimol-stimulated Cl Ϫ uptake in cerebral cortex as well as ligand binding autoradiography throughout brain. The results reveal interesting stable receptor adaptations that differ in some respects from adaptations observed in ␣1 Ϫ/Ϫ mice reported by Sur et al. (2001) . The goals of the present studies were to identify in vivo relationships between GABA A receptor subunit expression, receptor adaptations, function, and seizure susceptibility.
Materials and Methods
Subjects. Male and female wild-type (␣1 ϩ/ϩ ), heterozygous GABA A receptor ␣1 subunit knockout (␣1 ϩ/Ϫ ), and homozygous GABA A receptor ␣1 subunit knockout (␣1 Ϫ/Ϫ ) mice (Vicini et al., 2001) were derived from ␣1 ϩ/Ϫ breeding pairs at the University of North Carolina (Chapel Hill, NC) or the University of Pittsburgh (Pittsburgh, PA). The wild-type allele consisted of a floxed allele in which the exon encoding nucleotides 1307 to 1509 of the ␣1 subunit was flanked by loxP sites that lacked a selectable marker gene. The knockout ␣1 allele consisted of the floxed allele after cre-mediated recombination. Briefly, the floxed allele was produced in Strain 129/Sv/SvJ embryonic stem cells. Chimeric offspring derived from these cells were mated to C57BL/6J mice and subsequently interbred for one generation. These mice were crossed with an actin-cre general deleter mouse line (FVB/N genetic background) to produce the recombined allele (Lewandoski et al., 1997) . The cre transgene was subsequently eliminated from the pedigree. Mice that were heterozygous for the wild-type floxed allele and the recombined allele were interbred to produce the mice for experimental analysis. Thus, all mice were of the same mixed genetic background consisting of C57BL/6J (ϳ37.5%), 129/Sv/SvJ (ϳ37.5%), and FVB/N (ϳ25%). All animals were genotyped by Southern blot analysis, as described previously (Vicini et al., 2001) . After weaning, mice were group housed with same sex littermates, given free access to standard rodent chow and water, and maintained on a 12-h alternating light/ dark schedule with lights on at 7:00 AM. All studies were conducted with mice derived from F5 to F7 generations and were 8 to 13 weeks of age. All studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by each institution's Animal Care and Use committees.
Western Blot Analysis. After decapitation, cerebral cortex was rapidly dissected over ice, frozen on dry ice, and stored at Ϫ80°C. P2 membrane fractions from cerebral cortex were prepared by homogenization in phosphate-buffered saline buffer (150 mM NaCl and 10 mM Na 2 HPO 4 /Na 2 H 2 PO 4 , pH 7.4). Aliquots of 25 g protein/lane were separated by SDS-polyacrylamide gel electrophoresis under reducing conditions using an Xcell II minicell apparatus (Novex, San Diego, CA). Proteins were transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA). Blots were probed with GABA A receptor anti-peptide ␣1, ␣2, ␣3, ␣5, and ␥2 (Fritschy and Mohler, 1995) , ␣4 (Kern and Sieghart, 1994) , ␤2/3 (bd17; BMB, Indianapolis, IN), and ␦ (Quirk et al., 1995) antibodies. Antibodies were kind gifts from Drs. Jean-Marc Fritschy (University of Zurich, Zurich, Switzerland) and Werner Sieghart (University of Vienna, Vienna, Austria). Blots were then probed with horseradish peroxidase-conjugated anti-guinea pig (␣1, 2, 3, and 5 and ␥2), antirabbit (␣4 and ␦), or anti-mouse (␤2/3, actin) antibodies. Specific peptide labeling was detected by enhanced chemiluminescence (Pierce Chemical, Rockford, IL). Blots were apposed to X-ray film (Eastman Kodak, Rochester, NY) under nonsaturating conditions and analyzed by densitometric measurements (NIH Image 1.47). All Western blots were conducted under conditions in which densitometric signals were linear with protein concentration as determined in preliminary experiments. Blots were reprobed with actin and normalized to verify equivalent protein loading.
Radioligand Binding. After decapitation, brains were immediately removed and placed in ice-cold saline from which cerebral cortices were rapidly dissected over ice and either used immediately or frozen on dry ice and stored at Ϫ80°C. Membranes were prepared by homogenization of cerebral cortices from eight mice per genotype in 50 volumes of assay buffer (50 mM Tris-citrate, pH 7.4) with a Polytron homogenizer. Samples were centrifuged at 20,000g for 20 min and resuspended in wash buffer five times before freezing the pellets at Ϫ80°C overnight. Pellets were washed twice more to remove endogenous GABA and used at a final concentration of 1 mg/ml. High-affinity [ 3 H]muscimol (specific activity 30 Ci/mmol) (PerkinElmer Life Sciences, Boston, MA) binding was conducted over a concentration range of 0.5 to 100 nM in a final assay volume of 500 l and incubated for 90 min at 0 -4°C. Nonspecific binding was determined using 100 M GABA. The reaction was terminated by rapid filtration under vacuum (Ͻ25 in. Hg) using GF/B filter strips (Whatman, Maidstone, UK) pretreated with 0.03% polyethylenimine. Samples were washed twice with 3-ml aliquots of assay buffer at 0 -4°C. Filters were dried, added to liquid scintillation cocktail, and counted in a liquid scintillation counter. Saturation binding curves were evaluated using Prism (GraphPad Software, San Diego, CA) to obtain the K D and B max values and compared between genotypes by one-way ANOVA.
[ 3 H]SR-95531 (specific activity 59.1 Ci/mmol) binding (25 and 200 nM; PerkinElmer Life Sciences) was determined in fresh cerebral cortical membranes according to McCabe et al. (1988) , with minor modifications. Tissue was prepared by homogenization of cerebral cortices from two mice per genotype in 40 volumes of 0.32 M sucrose assay buffer (50 mM Tris-citrate, pH 7.4) with a Teflon homogenizer. Samples were centrifuged at 1000g for 10 min at 4°C from which the supernatant was centrifuged at 40,000 rpm in a rotor 41Ti (Beckman Coulter, Inc., Fullerton, CA) for 45 min at 4°C. The pellet was resuspended in double distilled H 2 O and centrifuged at 40,000 rpm for 30 min at 4°C before freezing at Ϫ80°C overnight. The following day, the pellet was resuspended in wash buffer and washed twice by centrifugation at 40,000 rpm for 15 min and used at a final concentration of 1.5 mg/ml. The final assay volume was 1 ml, and incubation took 45 min at 0 -4°C. Nonspecific binding was determined using 100 M GABA. The termination of the binding reaction, washing of the membrane filters, counting the radioactivity, and analyzing the data were carried out as described above for (Basel, Switzerland) . Picrotoxin was purchased from Sigma-Aldrich (St. Louis, MO). For autoradiography, 14-m horizontal or frontal serial sections were cut from three to five frozen mouse brains of each genotype using a cryostat (Microm), thaw-mounted onto gelatin-coated object glasses, and stored frozen under desiccant at Ϫ20°C. All experiments were carried out in parallel manner with respective genotype, eliminating any day-to-day variation in receptor assays between genotype. The autoradiographic procedures for regional localization of [ was greater than or equal to the dissociation constants for a range of recombinant and native GABA A receptors (Pritchett et al., 1989; Luddens et al., 1990; Pritchett and Seeburg, 1990; Wisden et al., 1991) . Therefore, the autoradiographic images should represent the density rather than affinity of binding sites. Autoradiography films were quantified using AIS image analysis system (Imaging Research, St. Catherines, Ontario, Canada) as described previously (Makela et al., 1997) . Binding densities for each brain area were averaged from measurements of one to three sections per brain. The standards exposed simultaneously with brain sections were used as reference with the resulting binding values given as radioactivity levels estimated for gray matter areas (nCi/mg for 3 H and nCi/g for 14 C). Significance between the mouse lines in different brain regions was assessed by two-way ANOVA followed by Bonferroni's post hoc test using Prism.
Chloride Uptake Assay. After decapitation, brains were immediately removed and placed in ice-cold saline. Cerebral cortices of seven mice per genotype were pooled for each experiment. Synaptoneurosomes were prepared and Cl Ϫ uptake was conducted as described previously (Morrow et al., 1988) . The synaptoneurosomal pellet was resuspended in 6.6 volumes of ice-cold assay buffer (20 mM HEPES, 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , and 2.5 mM CaCl 2 , pH 7.4) for a final protein concentration of approximately 5 mg/ml. The homogenate was aliquoted 200 l/assay tube and preincubated at 30°C for 12 min. Muscimol-stimulated Cl Ϫ uptake was initiated by addition of 0.2 Ci of 36 Cl (PerkinElmer Life Sciences) in the presence of various concentrations of muscimol (1-200 M). The solution was vortexed and uptake terminated after 5 s by addition of 4 ml of ice cold assay buffer containing 100 M picrotoxin with rapid vacuum filtration over G6 filters (Fisher Scientific, Pittsburgh, PA) using a single manifold filter apparatus (Hoeffer, San Francisco, CA). After two more washes, filters were allowed to dry and radioactive counts determined by liquid scintillation spectroscopy. Basal chloride uptake was measured in the absence of muscimol and subtracted from all tubes to determine muscimol-stimulated chloride uptake. Concentration-response curves were evaluated using computerized nonlinear regression (Prism; GraphPad Software) to obtain the EC 50 and E max values and compared between genotype by one-way ANOVA.
Bicuculline-Induced Seizure Threshold Test. Seizure thresholds were determined at the beginning of the light cycle as described previously (Devaud et al., 1995) . Mice were restrained in a Plexiglas plunger-style mouse restraint (Braintree Scientific, Braintree, MA). Threshold determination was made by constant lateral tail vein infusion of bicuculline (Sigma-Aldrich) dissolved in 0.1 N HCl, and diluted with isotonic saline to a final concentration of 0.05 mg/ml, pH 7. The solution was infused at a constant rate of 0.5 ml/min; the endpoint was taken as the first myoclonic jerk of the head and neck. This time point precedes forepaw clonus and generalized tonic/clonic convulsions. Each animal was tested once. Seizure thresholds were determined by experienced observers who were blind to the experimental conditions. Seizure thresholds were calculated from the time of infusion ϫ dose of bicuculline per body weight and presented as milligrams per kilogram of bicuculline. Data were analyzed by oneway ANOVA using Prism.
Results

␣1 Subunit Deletion Produces Selective Loss of ␤2/3
and ␥2 Subunit Peptides and Elevations in ␣2 and ␣3 Subunit Peptides. Western blot analysis demonstrated the successful elimination of ␣1 subunit peptide expression in cerebral cortex (Fig. 1) as well as whole brain (Vicini et al., 2001) . ␣1 ϩ/Ϫ and ␣1 Ϫ/Ϫ mice exhibited 39 Ϯ 3% (p Ͻ 0.0001) and 100% reductions in ␣1 subunit peptide expression in the P2 membrane fraction of cerebral cortex, respectively. Because the major GABA A receptor subtype containing ␣1 subunits expressed in brain is ␣l␤2␥2 (Barnard et al., 1998) , we measured the effect of the loss of ␣1 subunit expression on ␤2/3 and ␥2 subunit expression (Fig. 1) . Reductions in ␤2/3 subunit expression (35 Ϯ 4%; p Ͻ 0.01; 65 Ϯ 7%; p Ͻ 0.001) were observed in ␣1 ϩ/Ϫ and ␣1 Ϫ/Ϫ mice, respectively. Expression of ␥2 subunit peptide was reduced by 47 Ϯ 9% (p Ͻ 0.001) in ␣1 Ϫ/Ϫ mice. Adaptations in the expression of other GABA A receptor ␣ subunit variants were observed in ␣1 Ϫ/Ϫ mice. There were 37 Ϯ 4% (p Ͻ 0.001) and 39 Ϯ 6% (p Ͻ 0.001) increases in ␣2 and ␣3 subunit peptide expression, respectively, in ␣1 Ϫ/Ϫ mice. No significant differences in ␣4, ␣5, or ␦ subunit peptide expression were observed across genotypes. Data were analyzed from generations F5 to F7 and identical results were obtained (data not shown); therefore, data from all generations were collapsed in Fig. 1 Ϫ/Ϫ mice, by more than 50% in the thalamus, inferior colliculus, and cerebellum, decreased by approximately 25% in the cerebral cortex and basal ganglia, and 16% in the hippocampus. These results further confirm the reduction of GABA A receptor populations in the absence of ␣1 subunits at the functional protein level.
Benzodiazepine recognition sites on GABA A receptors have been divided into several classes based on pharmacological profiles of various compounds. The ␣1 subunit-containing (type I) receptors have high affinity for zolpidem, CL 218,872, and some ␤-carboline derivatives (Sieghart, 1989; GABA A receptor-mediated Cl Ϫ uptake was altered in the cerebral cortex in response to the loss of ␣1 subunit-containing receptors. Measurement of the ability of the GABA agonist muscimol to stimulate chloride ion uptake in cerebral cortical synaptoneurosomes was used to gauge GABA A receptor function after ␣1 subunit deletion. The maximal efficacy of muscimol-stimulated 36 Cl Ϫ uptake was reduced by 36 Ϯ 5% (p Ͻ 0.001) in ␣1 Ϫ/Ϫ mice, whereas a decrease in potency was detected by a 111 Ϯ 5% (p Ͻ 0.05) increase in the EC 50 of muscimol (Fig. 5) .
Behavioral Phenotype of ␣1 Subunit Knockout Mice. Breeding ␣1 ϩ/Ϫ mice resulted in a Mendelian distribution of genotypes among the offspring of 1:2:1 (␣1 ϩ/ϩ /␣1 ϩ/Ϫ /␣1 Ϫ/Ϫ ). The distribution of genotypes among offspring did not vary with generation or gender. Furthermore, the number of pups per litter (approximately eight) remained constant between generations. Knockout mice were overtly normal and indistinguishable from littermates except for a 25-Hz tremor when handled and a small, but significant reduction in body weight. In a sample of 60 to 70 mice per genotype, ␣1 Ϫ/Ϫ mice exhibited 10 Ϯ 3% (p Ͻ 0.01) lower body weights compared with wild-type mice between 9 and 12 weeks of age. A few ␣1 Ϫ/Ϫ mice seemed dwarfed at birth and oftentimes did not survive into adulthood.
Impaired GABA transmission leads to neuronal hyperexcitability, a condition associated with increased susceptibility to seizure (Macdonald and Olsen, 1994) . Bicuculline-induced seizure thresholds were measured to determine seizure susceptibility in ␣1 ϩ/Ϫ and ␣1 Ϫ/Ϫ mice. The latency to which a constant tail vein infusion of the direct GABA A receptor antagonist bicuculline caused seizure activity was measured and used to determine the dose of bicuculline required to meet the threshold to seizure. ␣1 Ϫ/Ϫ mice exhibited a 37 Ϯ 6% reduction (p Ͻ0.001) in seizure threshold (increased susceptibility to seizure) compared with ␣1 ϩ/ϩ mice (Fig. 6 ). Although not systematically quantified, ␣1 Ϫ/Ϫ mice exhibited more severe seizures that usually progressed to tonic clonic convulsions, wild running, clonus, and death. In contrast, ϩ/ϩ , ␣1 ϩ/Ϫ , and ␣1 Ϫ/Ϫ mice. The membrane fraction (P2) of cerebral cortex was examined using ␣1, ␣2, ␣3, ␣4, ␣5, ␤2/3, ␥2, and ␦ subunit-specific polyclonal antibodies. A, histogram of subunit expression showing data expressed as the percentage of control after normalization to ␤-actin expression. B, representative blot of subunit expression paired with corresponding ␤-actin expression. Data represent the mean Ϯ S.E.M. of three to six independent experiments of n ϭ 6 mice/genotype/ experiment and analyzed using a one-way ANOVA with Tukey's post hoc test. ૺૺ, p Ͻ 0.01; ૺૺૺ, p Ͻ 0.001 statistical significance compared with ␣1 ϩ/ϩ mice.
␣1
ϩ/ϩ mice rarely exhibited tonic clonic convulsions after the determination of seizure threshold.
Discussion
Production of mice with targeted deletion of individual GABA A receptor subunits has provided valuable insight into the contribution of specific receptor subtypes to CNS mechanisms controlling inhibitory tone, GABA-related disorders, and actions of drugs that act upon GABA A receptors. Likewise, the initial characterization of the ␣1 Ϫ/Ϫ mouse line has revealed several interesting phenomena related to ␣1 expression. Although the mice exhibit reduced GABA A receptor number and function and adaptations in GABA A receptor subunit expression, deletion of the ␣1 subunits resulted in viable offspring with a handling-induced tremor, but maintained normal fertility, litter size, and body weight across several generations. The overtly normal behavior of the mice is remarkable and suggests that the CNS expresses roughly twice as many GABA A receptors as required to maintain normal inhibitory tone. However, handling-induced tremor in ␣ Ϫ/Ϫ mice may suggest reduced CNS inhibition and increased seizure susceptibility in these mice provides evidence that further blockade of GABA A receptors severely impairs inhibitory neurotransmission.
The ␣1 Ϫ/Ϫ mice provide an interesting model to study the assembly of GABA A receptors. Deletion of the ␣1 subunit resulted in a dramatic reduction in the number of GABA A receptors in membrane fractions and brain sections presumably due to loss of the ␣1 subunit-containing receptors 3 H]Ro15-4513 autoradiographic binding is also consistent with this hypothesis. In a previous study, ␣ subunits were also shown to determine receptor assembly in vivo as deletion of ␣5 subunits in hippocampal pyramidal cells prevented receptor assembly and reduced receptor binding .
Absolute differences in brain regional binding levels were detected by autoradiographic analysis of [
35 S]TBPS versus [ 3 H]Ro15-4513 binding as described previously (Olsen et al., 1990; Turner et al., 1991; Makela et al., 1997; Korpi et al., 2002) . Furthermore, deletion of the ␣1 subunit differentially altered [
35 S]TBPS versus [ 3 H]Ro15-4513 within brain regions. These discrepancies are likely due to several factors, including differences in the receptor subtypes labeled by each ligand (Korpi et al., 2002) Benzodiazepine binding sites, located at the interface of ␣ and ␥2 subunits (for review, see Sigel and Buhr, 1997) , were severely affected by deletion of the ␣1 subunit. Complete loss of high-affinity [ 3 H]zolpidem binding in ␣1 Ϫ/Ϫ mice confirms the selectivity of this ligand for ␣1 subunit-containing receptors as described in vitro (Pritchett et al., 1989) . Previous studies suggest that up to 70% of BZD binding sites have properties of ␣1 subunit-containing (type I) receptors (Braestrup and Nielsen, 1981; Niddam et al., 1987; Dennis et al., 1988) . However in ␣1
Ϫ/Ϫ mice, we observed a loss of 46% of Elegant studies conducted in knockin mice containing a point mutation at the BZD binding site of the ␣ subunit have provided models in which the behavioral responses to an array of BZD site ligands have been selectively attenuated without affecting receptor assembly or sensitivity to GABA (for review, see Rudolph et al., 2001) . In ␣1(H101R) mice, the sedative and amnesic effects of diazepam were ablated, whereas the seizure-protective effect was partially reduced (Rudolph et al., 1999) . Similar studies conducted in ␣2(H101R) and ␣3(H101R) mice have attributed the anxiolytic effects of diazepam to ␣2-containing receptors (Low et al., 2000) . Together, these studies have begun to dissociate the receptor subtypes responsible for the anxiolytic, sedative, myorelaxant, motor-impairing, hypnotic, amnesic, and ethanol-potentiating effects of BZDs. Furthermore, the pharmacological and behavioral profile of current and future selective BZDs can be examined in these mice (e.g., zolpidem) . These results would predict that the ␣1 Ϫ/Ϫ mice will exhibit a loss of the sedative-hypnotic effects of diazepam and zolpidem with a partial loss in the anticonvulsant effect of diazepam. We have observed a complete loss of the ability of diazepam (1-30 mg/kg) to prevent bicuculline-induced seizures in ␣1 Ϫ/Ϫ mice ). Additional studies are underway to further compare these models.
The alterations in muscimol-stimulated 36 Cl Ϫ uptake in Ϫ/Ϫ mice. Studies in stably transfected mouse L(tk Ϫ ) cells reported that the maximal effect of muscimol-stimulated chloride flux varies with expression levels of ␣1, ␣5, or ␣6 subunits in conjunction with the ␤ and ␥ subunits (Harris et al., 1998) . Several in vivo studies suggest that the presence of the ␣1 subunit contributes to the efficacy of GABA agonists. Knockdown of ␣1 subunits using antisense deoxyoligonucleotides resulted in a decrease in GABA-mediated chloride flux (Malatynska et al., 2000) . Patch-clamp recordings measured a reduction in the amplitude of evoked inhibitory postsynaptic currents in slices from visual cortex after treatment with ␣1 antisense deoxyoligonucleotides (Brussaard and Baker, 1995) . A decrease in ␣1 subunit mRNA and peptide expression has been associated with a decrease in the E max of muscimol-stimulated chloride flux after chronic ethanol administration (Morrow et al., 1988 ; ϩ/ϩ , ␣1 ϩ/Ϫ , and ␣1 Ϫ/Ϫ mice (n ϭ 7-8 mice/genotype/experiment). The maximal response (E max ) to muscimol was significantly reduced from 30.4 Ϯ 1.1 to 21.7 Ϯ 0.7 nmol of Cl Ϫ /mg of protein in ␣1 ϩ/ϩ and ␣1 Ϫ/Ϫ mice, respectively, with a slight reduction to 28.8 Ϯ 1.4 nmol of Cl Ϫ /mg of protein in ␣1 ϩ/Ϫ mice. The potency of muscimol was significantly reduced from 3.7 Ϯ 0.6 to 7.9 Ϯ 1.0 M in ␣1 ϩ/ϩ and ␣1 Ϫ/Ϫ mice, respectively, with a slight reduction to 5.0 Ϯ 0.7 M in ␣1 ϩ/Ϫ mice. Data represent the mean Ϯ S.E.M. of four independent experiments each conducted in quadruplicate and analyzed using a one-way ANOVA with Tukey's post hoc test. jpet.aspetjournals.org Devaud et al., 1997) , whereas there is no change in total receptor number (for review, see Grobin et al., 1998) . Although these studies support the hypothesis that ␣1 subunits contribute to the functional capacity of the receptor, a reduction in GABA A receptor number may also contribute to the loss of agonist efficacy. In addition, the reduced potency of muscimol in ␣1 Ϫ/Ϫ mice suggests that ␣ subunits modulate the potency of muscimol, a property that should not be affected by receptor number, but is consistent with lower GABA sensitivities of ␣2 and ␣3 subunit-containing receptors than ␣1 subunit-containing receptors (Lü ddens and Korpi, 1995) .
The present study demonstrates that GABA A receptor subunit expression and function are altered in the cerebral cortex of ␣1 Ϫ/Ϫ mice. In a previous study using these mice, Vicini et al. (2001) The decrease in bicuculline-induced seizure threshold measured in ␣1 Ϫ/Ϫ mice suggests that ␣1 subunit-containing receptors influence seizure susceptibility through maintenance of inhibitory tone. As described earlier, a strong association between the expression of the ␣1 subunit and seizure susceptibility has been drawn from developmental, epileptic, and alcohol dependence and withdrawal models. The developing brain expresses predominately GABA A receptor ␣2, ␣3, and ␣5 subunits during embryonic and early postnatal stages shifting to high levels of ␣1 subunit expression in adult brain (Poulter et al., 1992; Laurie et al., 1992) . This switch in the expression pattern of ␣ subunits during brain development is associated with a decreased seizure susceptibility in adult brain (Aicardi and Chevrie, 1970; Mecarelli et al., 1988) . Moreover, models of seizure-prone and -resistant mice express 50% less and 200% more ␣1 subunit than controls, respectively (Poulter et al., 1999) . Withdrawn ethanol-dependent rats exhibit increased seizure susceptibility and a concomitant reduction in ␣1 subunit expression (Devaud et al., 1997) . These findings support the hypothesis that ␣1 subunit expression serves a critical role in regulating CNS excitability and seizure susceptibility and a potential target for anticonvulsant drug therapy.
Recently, production of an ␣1 subunit knockout mouse (MSD mice; Sur et al., 2001 ) was achieved using a different gene targeting method (Sur et al., 2001; Vicini et al., 2001) . Although both mouse lines share mostly similar phenotypes, they also differ in several ways. In addition to the successful deletion of the ␣1 subunit and production of viable knockout mouse lines, both lines exhibited similar changes in GABA A receptor pharmacology and an absence of any overt behavioral differences. Furthermore, both lines displayed increased peptide expression of ␣2 and ␣3 subunits. Although these adaptations were consistent across generations in our mouse line, the adaptations were gradually lost in successive generations of MSD mice (Sur et al., 2001 ). This difference is likely due to distinct gene-targeting methods or breeding strategies used. Interbreeding of ␣1 Ϫ/Ϫ mice may have resulted in the smaller litter sizes observed in MSD mice in earlier generations. Litter sizes may have recovered in size due to selection of knockout mice able to survive ␣1 gene deletion or those containing adaptations in ␣2 and ␣3 subunit expression. Measurement of mRNA revealed no adaptations in ␤3 and ␥2 expression in MSD mice (Sur et al., 2001) , whereas ␤2/3 and ␥2 peptide expression was significantly reduced in our mice, suggesting either another inherent difference between lines or adaptations in subunit expression mediated by translational control or assembly mechanisms. Although functional studies conducted in both mouse lines used different methods and targeted different brain regions, they collectively showed that GABA A receptor function is diminished in the absence of ␣1 subunit expression. Differences between these mouse lines may be inherent to the line or due to varying techniques used for breeding and investigation. Together, these independent studies provide a thorough examination of the role of the ␣1 subunit in GABA A receptor pharmacology, function, and related behaviors.
In conclusion, we have shown that global deletion of the ␣1 subunit of the GABA A receptor results in reduced agonistinduced receptor function, BZD pharmacology, and increased seizure susceptibility without affecting viability or overt behavior. The increased seizure susceptibility of ␣1 Ϫ/Ϫ mice supports the role of ␣1 subunit expression in the maintenance of CNS inhibitory tone suggested by models of epilepsy and alcohol withdrawal. Adaptations in GABA A receptor subunit expression provide further evidence for plasticity in the GABAergic system. Results from the present studies suggest a specific role for ␣1 subunit-containing receptors in GABAergic neurotransmission and extend previous findings supporting the ␣1 subunit-containing receptor as a target for the development of GABA A receptor subtype-specific drugs, e.g., for new antiepileptic/anticonvulsant drugs. Our new mouse model will be useful in the study of mechanisms that regulate GABA A receptor assembly as well as testing possible new drug entities. Furthermore, important pharmacodynamic studies remain such as determining the response of ␣1 Ϫ/Ϫ mice to the actions of benzodiazepines, alcohol, volatile anesthetics, barbiturates, and neurosteroids, all of which act upon GABA A receptors.
